3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Recruiting
2
Completed
2
Unknown
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Pain, Postoperative
3
Breast Neoplasms
3
Colorectal Neoplasms
2
Colonic Neoplasms
2
Chronic Pain
2
Squamous Cell Carcinoma of Head and Neck
1
Postoperative Hemorrhage
1
Pilonidal Sinus
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Carcinoma, Squamous Cell
1
Interventions
Oxaliplatin
13
Bevacizumab
11
Capecitabine
10
Fluorouracil
8
Blood Specimen Collection
8
Leucovorin
7
Cetuximab
6
pembrolizumab
5
Folfox protocol
5
trifluridine tipiracil drug combination
4
dostarlimab
4
Nivolumab
4
Irinotecan
4
HMPL-013
4
Drug Therapy
4
fludarabine
3
XELOX
3
Specimen Handling
3
Laparoscopy
3
IFL protocol
3
Cyclophosphamide
3
Biopsy
3
tislelizumab
2
tipiracil
2
regorafenib
2
pertuzumab
2
envafolimab
2
encorafenib
2
cemiplimab
2
atezolizumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Colonic Neoplasms
×
Lidocaine
×
Clear all
NCT07432399
2026-03-06
PILDI
Institute of Oncology Ljubljana
Phase 2
Recruiting
100 enrolled
NCT06923787
2026-02-05
PILDI
Institute of Oncology Ljubljana
Phase 2
Recruiting
100 enrolled